Categories

Tag: Bayer G4A

This Digital Health Tool is Proven to Improve Cognitive Fitness | Jean Castonguay, NeuroTracker

By JESSICA DAMASSA, WTF HEALTH

Neuroscience startup, NeuroTracker, has a virtual training tool with a proven ability to help improve “cognitive fitness.” Jean Castonguay, co-founder, board member and Head of Global Strategic Partnerships at NeuroTracker, explains the science and clinical validation behind their tech and drops some big name users in the process — Manchester United, German and French soccer teams, US special forces, as well as some of the world’s leading sports concussion rehabilitation clinics. What sets the startup apart from other companies in the mental performance space? How have they shored up their science in the face of Lumosity’s Federal Trade Commission suit against false claims about brain health outcomes? It shook up the industry, and NeuroTracker actually feels it strengthened their business and their value proposition.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Health in 2 Point 00, Episode 99 | (Reverse) Takeover Edition with Bayer G4A

Today on Health in 2 Point 00… hold on, where’s Jess? On Episode 99, I do a reverse takeover with Priyanka Kashyap and Sophie Park at Bayer’s office in Berlin. Priyanka tells us about what Bayer G4A is doing these days with the 5 startups in their Advance Track: Blackford Analysis in radiology; Carepay and RelianceHMO improving affordability and access for patients in Africa; NeuroTracker, which is in the neuro space but is working with the oncology team at Bayer; and Prevencio, a diagnostic solution in the cardiovascular space. Sophie also gives us a rundown of the 6 startups in the Growth Track at G4A: Wellthy, a digital therapeutics company out of India; Litesprite, for mental health; BioLum, a pulmonology startup working on detecting nitric oxide levels in the blood; Upside Health with its chronic pain management software; and finally Visotec and Okko Health in ophthalmology. —Matthew Holt

Health in 2 Point 00, Episode 97 | Walmart and Fertility

Today on Health in 2 Point 00, Jess is in Berlin for the Bayer G4A Signing Day where they’re announcing which startups are going to get deals and Glen Tullman is doing a fireside chat with Eugene Borukhovich. In Episode 97, Jess and I talk about Walmart and fertility. Fertility benefits startup Progyny files for IPO and I’m blown away by this relatively new company. Another startup—Halle Tecco’s Natalist—raises $5M to send care boxes to help women get pregnant. Finally, Jess has a conspiracy theory, noticing that Walmart is sneaking into all aspects of health tech… Walmart is expanding Grand Rounds, partnering with Doctor On Demand and HealthSCOPE to offer telehealth to their employees, Sam’s Club is offering $1 telehealth visits to members, and they just announced a partnership with Embold Health for employees in the southeast. Finally, I’ll be at Society for Participatory Medicine next week in Boston—see you all there. —Matthew Holt

Will Digital Therapeutics be ‘The End’ of Digital Health? | Eugene Borukhovich, G4A Bayer

By JESSICA DAMASSA, WTF HEALTH

How are ‘digital therapeutics’ different than what we’ve already been doing in ‘digital health’? Eugene Borukhovich, Global Head of Digital Health for Bayer, talks about how he thinks eventually the term ‘digital health’ will just disappear. What’s behind this prediction? Listen in to find out.

Filmed at JP Morgan Healthcare Conference, San Francisco, January 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew Holt.

Get a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health

Registration

Forgotten Password?